PTGX Insider Trading Activity and SEC Form 4 Filings
Trump's trades in PTGX
From his financial disclosures
-
0 purchases
$30K+
2 sales
Sale
Jul 29, 2026
Reported 55d later
$15K - $50K
Sale
May 15, 2026
Reported 47d later
$15K - $50K
Many orders in these accounts are placed by the account manager.
PTGX insider trading summary
Over the past 12 months, insiders at Protagonist Therapeutics, Inc (PTGX) reported 29 sales worth $80.9M by 6 insiders and no open-market purchases on SEC Form 4. Net insider selling was $80.9M.
Latest PTGX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Asif Ali | Chief Financial Officer | Sell | $1.8M (12,595 @ $141.77) |
| Sep 30, 2026 | Asif Ali | Chief Financial Officer | Sell | $6.5M (46,034 @ $141.78) |
| Sep 10, 2026 | Dinesh V Ph D Patel | President and CEO | Sell | $1.0M (7,278 @ $144.10) |
| Sep 9, 2026 | Dinesh V Ph D Patel | President and CEO | Sell | $9.3M (63,548 @ $146.18) |
| Sep 8, 2026 | Dinesh V Ph D Patel | President and CEO | Sell | $7.9M (54,174 @ $145.87) |
| Aug 11, 2026 | Dinesh V Ph D Patel | President and CEO | Sell | $5.1M (34,239 @ $148.52) |
| Aug 10, 2026 | Dinesh V Ph D Patel | President and CEO | Sell | $9.8M (65,761 @ $149.11) |
| Jun 10, 2026 | William D. Waddill | Director | Sell | $969K (9,000 @ $107.68) |
| May 12, 2026 | Dinesh V Ph D Patel | President and CEO | Sell | $7.5M (75,000 @ $100.12) |
| May 12, 2026 | Dinesh V Ph D Patel | President and CEO | Sell | $7.5M (75,000 @ $100.12) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.